The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cellsRobert Hromas(The University of Texas at San Antonio Health Science Center), Kimi Kong(University of Florida Health)Breast Cancer ResearchNovember 16, 201710.1186/s13058-017-0912-8Cited by 39SaveCiteExport RISWatch citationsRelated PapersChemokine Regulation of Normal and Pathologic Immune Responses|Stem Cells|2001|138EEPD1 Rescues Stressed Replication Forks and Maintains Genome Stability by Promoting End Resection and Homologous Recombination Repair|PLoS Genetics|2015|82NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations|Oncotarget|2017|17